Diagnostic Products Corp. AIP Problems Compounded By Grand Jury Subpoena
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic Products Corp. intends to report to the U.S. Attorney General's office by October on prior transactions that may have constituted insider trading